The Mammography Quality Standards Act (MQSA) of 1992 is intended to ensure that mammography practice nationwide meets consistent baseline quality standards. Amendments to the MQSA implementing regulations ("Amendments") were published on March 10, 2023, and are effective on September 10, 2024. The Amendments address various aspects of the program, including mammography technology, enforcement, the retention and transfer of personnel records and medical records, the medical outcomes audit, and mammography reporting, including (but not limited to) reporting of breast tissue density. The amended regulations are available online, and the Food and Drug Admininstration (FDA) offers several resources for mammography facilities and other stakeholders to receive additional information, including a facility hotline, a summary document distributed to all certified mammography facilities, and a Small Entity Compliance Guide (or SECG) written in question-and-answer format, which the FDA intends to be helpful to facilities of any size.

中文翻译：

---

MQSA 实施条例 2023 年修正案的要点。


1992 年的《乳房 X 光检查质量标准法案》(MQSA) 旨在确保全国范围内的乳房 X 光检查实践符合一致的基线质量标准。 MQSA 实施条例修正案（“修正案”）于 2023 年 3 月 10 日发布，并于 2024 年 9 月 10 日生效。修正案涉及该计划的各个方面，包括乳房 X 光检查技术、执行、人事记录的保留和转移医疗记录、医疗结果审核和乳房X光检查报告，包括（但不限于）乳腺组织密度报告。修订后的法规可在线获取，美国食品和药物管理局 (FDA) 为乳腺 X 光检查设施和其他利益相关者提供多种资源以获取更多信息，包括设施热线、分发给所有经过认证的乳腺 X 光检查设施的摘要文件以及小实体合规性以问答形式编写的指南（或 SECG），FDA 旨在对任何规模的机构有所帮助。